GILEAD SCIENCES, INC. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-08-06: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-06: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-06: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-05-07: Disclosure Non Rule10b51Arr Terminated; Period 2026-01-01..2026-03-31; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-08-06 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-06 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-06 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-05-07 10-Q | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-05-07 10-Q | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-05-07 10-Q | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-03-20 DEF 14A | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2026-03-20 DEF 14A | Award Timing MNPI Disclosure | 2025-01-01..2025-12-31 | Equity Grant Practices The Compensation and Talent Committee generally approves the target value of annual equity awards for the company’s executive officers, including each of the Named Executive Officers, at its regularly scheduled meeting in late January or early February of each year, with a gra… | |
| 2026-03-20 DEF 14A | Award Timing Method | 2025-01-01..2025-12-31 | The Compensation and Talent Committee generally approves the target value of annual equity awards for the company’s executive officers, including each of the Named Executive Officers, at its regularly scheduled meeting in late January or early February of each year, with a grant date to be effective… | |
| 2026-03-20 DEF 14A | Award Timing Predetermined | 2025-01-01..2025-12-31 | Yes | |
| 2026-03-20 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2025-01-01..2025-12-31 | No | |
| 2026-03-20 DEF 14A | Award Timing How MNPI Considered | 2025-01-01..2025-12-31 | The company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. | |
| 2026-03-20 DEF 14A | Awards Close To MNPI Disclosure Table | 2025-01-01..2025-12-31 | Due to this Form 8-K event, as required by SEC rules, the table below sets forth certain information about the annual stock option grants made to our Named Executive Officers. Name Grant Date Number of Securities Underlying the Award Exercise Price of the Award ($/Sh) Grant Date Fair Value of the Aw… | |
| 2026-03-20 DEF 14A | Awards Close To MNPI Disclosure Individual Name | Individual: ODay | 2025-03-10 | Daniel P. O’Day |
| 2026-03-20 DEF 14A | Award Undrlyg Securities | Individual: ODay | 2025-03-10 | 169,690 |
| 2026-03-20 DEF 14A | Award Exrc Price | Individual: ODay | 2025-03-10 | 117.21 |
| 2026-03-20 DEF 14A | Award Grant Date Fair Value | Individual: ODay | 2025-03-10 | $4.50M |
| 2026-03-20 DEF 14A | Undrlyg Security Mkt Price Chng Pct | Individual: ODay | 2025-03-10 | -0.009 |
| 2026-03-20 DEF 14A | Awards Close To MNPI Disclosure Individual Name | Individual: Dickinson | 2025-03-10 | Andrew D. Dickinson |
| 2026-03-20 DEF 14A | Award Undrlyg Securities | Individual: Dickinson | 2025-03-10 | 49,020 |
| 2026-03-20 DEF 14A | Award Exrc Price | Individual: Dickinson | 2025-03-10 | 117.21 |
| 2026-03-20 DEF 14A | Award Grant Date Fair Value | Individual: Dickinson | 2025-03-10 | $1.30M |
| 2026-03-20 DEF 14A | Undrlyg Security Mkt Price Chng Pct | Individual: Dickinson | 2025-03-10 | -0.009 |
| 2026-03-20 DEF 14A | Awards Close To MNPI Disclosure Individual Name | Individual: Mercier | 2025-03-10 | Johanna Mercier |
| 2026-03-20 DEF 14A | Award Undrlyg Securities | Individual: Mercier | 2025-03-10 | 49,020 |
| 2026-03-20 DEF 14A | Award Exrc Price | Individual: Mercier | 2025-03-10 | 117.21 |
| 2026-03-20 DEF 14A | Award Grant Date Fair Value | Individual: Mercier | 2025-03-10 | $1.30M |
| 2026-03-20 DEF 14A | Undrlyg Security Mkt Price Chng Pct | Individual: Mercier | 2025-03-10 | -0.009 |
| 2026-03-20 DEF 14A | Awards Close To MNPI Disclosure Individual Name | Individual: Berger | 2025-03-10 | Dietmar Berger, M.D., Ph.D. |
| 2026-03-20 DEF 14A | Award Undrlyg Securities | Individual: Berger | 2025-03-10 | 37,710 |
| 2026-03-20 DEF 14A | Award Exrc Price | Individual: Berger | 2025-03-10 | 117.21 |
| 2026-03-20 DEF 14A | Award Grant Date Fair Value | Individual: Berger | 2025-03-10 | $1.00M |
| 2026-03-20 DEF 14A | Undrlyg Security Mkt Price Chng Pct | Individual: Berger | 2025-03-10 | -0.009 |
| 2026-03-20 DEF 14A | Awards Close To MNPI Disclosure Individual Name | Individual: Telman | 2025-03-10 | Deborah H. Telman |
| 2026-03-20 DEF 14A | Award Undrlyg Securities | Individual: Telman | 2025-03-10 | 33,940 |
| 2026-03-20 DEF 14A | Award Exrc Price | Individual: Telman | 2025-03-10 | 117.21 |
| 2026-03-20 DEF 14A | Award Grant Date Fair Value | Individual: Telman | 2025-03-10 | $900.07K |
| 2026-03-20 DEF 14A | Undrlyg Security Mkt Price Chng Pct | Individual: Telman | 2025-03-10 | -0.009 |
| 2026-03-20 DEF 14A | Pay versus Performance Table | 2025-01-01..2025-12-31 | Pay Versus Performance As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive “compensation actually paid” and certain financial performance… | |
| 2026-03-20 DEF 14A | Additional402v Disclosure | 2025-01-01..2025-12-31 | As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive “compensation actually paid” and certain financial performance of the company. For fu… | |
| 2026-03-20 DEF 14A | Named Executive Officers Footnote | 2025-01-01..2025-12-31 | (1) The dollar amounts reported are the amounts reported in the “Total” column of the Summary Compensation Table for our Chairman and Chief Executive Officer, Mr. O’Day. (3) The dollar amounts reported represent the average of the amounts reported for our NEOs as a group (excluding our CEO) in the “… | |
| 2026-03-20 DEF 14A | Adjustment To PEO Compensation Footnote | 2025-01-01..2025-12-31 | (2) The dollar amounts reported represent the amount of “compensation actually paid”, as computed in accordance with SEC rules, for Mr. O’Day . The dollar amounts do not reflect the actual amount of compensation earned by or paid during the applicable year. In accordance with SEC rules, the followin… | |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | $19.74M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | $54.56M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $16.55M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $37.65M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $15.62M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $8.49M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $14.35M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $47.70M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $13.14M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $25.39M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | $20.07M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | $25.07M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | $8.25M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: Peo | 2025-01-01..2025-12-31 | $1.17M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $23.96M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $13.33M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | -$1.03M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $1.39M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $12.53M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | -$2.48M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | -$2.86M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $1.31M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $34.15M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $14.18M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$1.97M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $1.33M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $17.16M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $6.01M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $707.26K |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $1.51M |
| 2026-03-20 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2025-01-01..2025-12-31 | (4) The dollar amounts reported represent the average amount of “compensation actually paid” to the NEOs identified in footnote 3, as computed in accordance with SEC rules. The dollar amounts do not reflect the actual amount of compensation earned by or paid to any NEO during the applicable year. In… | |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $5.86M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $9.86M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $4.83M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $11.29M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $4.81M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $2.69M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $4.96M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $15.27M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $3.63M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $7.04M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $5.52M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $4.16M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $1.80M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$1.75M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $133.72K |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $6.88M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $4.26M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$282.47K |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $0.00 |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $434.11K |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $3.96M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$789.32K |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$879.50K |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $0.00 |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $403.12K |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $11.75M |
| 2026-03-20 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $3.37M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |